Learn which Lexapro withdrawal symptoms to watch for, how long they can last and how to taper off escitalopram safely in smaller steps.
Key takeaways
- Lexapro has a half-life of 27 to 32 hours, so withdrawal symptoms usually start within a few days of a dose reduction.
- The prescribing information recommends a gradual taper and, if symptoms become intolerable, going back to the previous dose.
- Liquid escitalopram allows much smaller dose changes than tablets, but the pace should always be set with your prescriber.
Introduction: Why Coming Off Lexapro Needs a Plan
Someone has been taking Lexapro for a year. The anxiety that led them to start treatment has eased a lot, so together with their prescriber they decide it’s time to stop. A few days after dropping to a lower dose, they feel dizzy, on edge and notice brief “zaps” when they turn their head. Their first worry is that the anxiety is coming back.
If you’re thinking about coming off Lexapro, you probably know you shouldn’t stop it overnight. Fewer people know how much the pace of the taper matters, or that the form of the medication can make it possible to take very small steps.
This article covers what the FDA prescribing information and guidelines say, which Lexapro withdrawal symptoms to expect and how long they can last, what makes tapering harder, how Lexapro compares with other SSRIs and the principles behind a safer reduction. The key point: symptoms after a dose cut don’t necessarily mean your condition is back, and your nervous system needs time to adjust to every change.
Planning to come off Lexapro and want to do it carefully? Book a free discovery call.
What Is Lexapro and How Does It Work?
Lexapro (escitalopram) is a selective serotonin reuptake inhibitor (SSRI) prescribed for depression and generalized anxiety disorder. It blocks the serotonin transporter, so serotonin stays active for longer between nerve cells.
According to the FDA prescribing information, Lexapro has an average half-life of 27 to 32 hours, peak blood levels occur about 5 hours after a dose, and steady state is reached within about a week. Its main metabolite, S-DCT, circulates at about a third of the level of escitalopram and is at least seven times weaker, so it doesn’t contribute meaningfully to the drug’s effect. For a closer look at how half-life shapes tapering, see Zoloft half-life, which walks through the same principles for another SSRI.
What Do the FDA and Guidelines Say About Stopping Lexapro?
The Lexapro prescribing information notes that discontinuation symptoms have been reported, particularly after stopping abruptly. They’re generally self-limiting, but serious cases have been reported too. The manufacturer recommends a gradual dose reduction rather than abrupt cessation and states that if intolerable symptoms occur after a dose cut, going back to the previous dose may be considered, with the dose then lowered more gradually.
The UK’s NICE guideline (2022) advises discussing possible withdrawal symptoms before stopping, reducing the dose in stages and tailoring the pace to the individual. The Royal College of Psychiatrists notes that for some people withdrawal symptoms can last longer than a few weeks.
A 2019 systematic review by Davies and Read found that more than half of people coming off antidepressants experience withdrawal symptoms, and nearly half of them describe those symptoms as severe. A 2024 meta-analysis in The Lancet Psychiatry, based mostly on shorter clinical trials, put the incidence at about 31%, with severe symptoms in about 3%.
Lexapro Withdrawal Symptoms
The prescribing information lists symptoms including low mood, irritability, agitation, dizziness, sensory disturbances, anxiety, confusion, headache, lethargy, emotional ups and downs, insomnia and hypomania. Not everyone experiences them.
Physical Symptoms
- Dizziness: often worse with quick head movements.
- Headaches and lethargy: feeling heavy and drained.
- Nausea and stomach upset: common in the first days after a reduction.
- Insomnia: trouble falling asleep and vivid dreams.
Emotional and Mental Symptoms
- Irritability and agitation: stronger reactions to everyday situations.
- Anxiety and low mood: easy to mistake for relapse.
- Emotional ups and downs and confusion: trouble concentrating, sometimes described as Lexapro brain fog.
- Hypomania: less common unusual energy or elevated mood, which needs prompt contact with your prescriber.
Sensory Disturbances and Brain Zaps
The prescribing information describes sensory disturbances such as tingling and electric shock sensations. Many people call them brain zaps and notice them when they move their eyes or head.
How Long Does Lexapro Withdrawal Last?
The course is individual. Based on the prescribing information and withdrawal research, a general pattern looks like this:
- First few days after a reduction: with a 27- to 32-hour half-life, drug levels fall noticeably within days, and some people notice the first symptoms.
- First few weeks: symptoms may come and go in waves, often in step with each dose change.
- Following weeks and months: for many people symptoms gradually fade, but the Davies and Read review found they often last longer than one to two weeks.
- Beyond a few months: some people develop protracted withdrawal.
What Affects How Hard It Is to Come Off Lexapro?
How Long You’ve Been Taking It
A 2023 review in CNS Drugs found that longer antidepressant use is linked to more frequent and more severe withdrawal. After years on Lexapro, tapering usually takes longer.
Your Dose
Higher doses showed only a weak link to risk. More important is that at low doses, even a small change has a big effect on serotonin transporter occupancy, as Horowitz and Taylor described in 2019. That’s why the final steps are often the hardest.
Age
In two studies described in the prescribing information, Lexapro’s half-life was about 50% longer in people aged 65 and older than in younger adults, so the drug stays in the body longer.
Liver Function
Escitalopram is broken down mainly in the liver. In people with reduced liver function, the half-life of citalopram, the parent compound, doubled, and the prescribing information recommends lower doses in this group.
Genetics
The enzyme CYP2C19 helps metabolize escitalopram. A 2023 guideline from the Clinical Pharmacogenetics Implementation Consortium (CPIC) notes that CYP2C19 poor metabolizers have higher escitalopram levels, which may raise the risk of side effects.
Lexapro Compared With Other Antidepressants
Withdrawal risk varies between drugs. The table combines half-lives from the FDA prescribing information with risk findings from the 2023 CNS Drugs review.
| Medication | Half-life | Withdrawal risk |
|---|---|---|
| Prozac (fluoxetine) | 4-6 days with long-term use (metabolite 4-16 days) | Symptoms may come later and milder, but can still occur |
| Celexa (citalopram) | About 35 hours | No evidence of especially high risk |
| Lexapro (escitalopram) | About 27-32 hours | No evidence of especially high risk |
| Zoloft (sertraline) | About 26 hours | No evidence of especially high risk |
| Paxil (paroxetine) | About 21 hours | Higher than other SSRIs |
| Effexor XR (venlafaxine, SNRI) | About 5 hours (metabolite about 11 hours) | Higher than most SSRIs |
So Lexapro isn’t among the highest-risk drugs, but withdrawal from it is well documented. For a comparison with another common SSRI, see how to taper off Zoloft safely.
Lexapro Formulations and Making Small Dose Changes
A gradual taper calls for progressively smaller doses. The table shows which forms of escitalopram make that possible in the US.
| Form | Strengths | Small dose changes | Notes |
|---|---|---|---|
| Tablets | 5mg, 10mg, 20mg | Limited | Big gaps between strengths |
| Split tablets | 10mg and 20mg tablets are scored | Moderate | Less precise for very small portions |
| Oral solution (generic) | 1mg/mL | High | Brand-name Lexapro solution isn’t currently marketed |
| Compounded medication | Dose set by your prescriber | High | Requires a prescription and a compounding pharmacy |
Horowitz and Taylor note that liquid formulations allow precise, small dose changes. A 1mg/mL solution makes it possible to measure doses well below the smallest tablet, which can matter most toward the end of a taper.
Is It Withdrawal or Relapse?
Some withdrawal symptoms resemble anxiety or depression, so they’re easily mistaken for a relapse, which can lead straight back to a full dose. Useful clues include timing (usually within a few days of a reduction), the type of symptoms (dizziness and brain zaps aren’t symptoms of depression) and quick improvement after going back to the previous dose. For more, read how to tell antidepressant withdrawal from relapse.
Acute and Prolonged Withdrawal
Acute Withdrawal
Symptoms appear within days or weeks of a dose cut and, for most people, fade gradually. Their intensity depends on the pace of the taper, how long you’ve been on the drug and individual sensitivity.
Prolonged Withdrawal
For some people symptoms last beyond six weeks, sometimes for months or years. Hengartner and colleagues described this pattern in 2020 based on accounts from people seeking help online. Sexual dysfunction that persists after treatment (PSSD) is a separate issue, and since 2019 SSRI product information has carried a warning about it following a European Medicines Agency recommendation. See Lexapro sexual side effects and protracted withdrawal for more.
How to Taper Off Lexapro Safely
Why Gradual Reduction Matters
Every dose change requires your nervous system to adjust. A gradual taper spreads those changes out and leaves room to respond if symptoms build. As the prescribing information notes, if symptoms become intolerable, going back to the previous dose and then tapering more slowly may be considered, always with your prescriber. For practical approaches, see safe strategies for tapering antidepressants.
Hyperbolic Tapering
Hyperbolic tapering means making progressively smaller reductions, especially toward the end. The pace and size of each step are set with your prescriber. Horowitz and Taylor also describe that some prescribers consider switching to a drug with a long half-life before stopping, though evidence for this approach is limited. The guide to hyperbolic tapering of antidepressants explains the method in detail.
Easing Symptoms Along the Way
- Symptom log: tracking dose changes and symptom severity helps judge the pace.
- Steady routine: regular sleep, meals and moderate exercise may make day-to-day life easier.
- Calmer timing: plan reductions away from major life changes.
- Support from people close to you: read more about why support matters during withdrawal.
Having an Informed Conversation with Your Prescriber
It helps to go into the appointment with your questions ready. You might ask:
- Pace: How quickly should I reduce my dose, given how long I’ve been on Lexapro and my past experience?
- Formulation: Could I switch to the liquid or a compounded version for the smaller doses?
- Symptoms: How can I tell withdrawal from relapse, and when should I contact you?
- Plan B: What do we do if symptoms after a reduction are too strong?
- Check-ins: How often should we be in touch while I’m tapering?
Frequently Asked Questions
Can you stop Lexapro cold turkey?
The prescribing information recommends a gradual reduction rather than stopping abruptly, because abrupt cessation raises the risk of withdrawal symptoms, including serious ones. In some medical situations a prescriber may decide to stop treatment faster, but it shouldn’t be a decision you make on your own.
How long does it take to taper off Lexapro?
The taper itself usually takes weeks to months, depending on how long you’ve been on the medication and how your body responds. For many people withdrawal symptoms clear within a few weeks, but for some they last longer, so it helps to keep the plan flexible.
Is Lexapro harder to stop than Zoloft?
The two have similar half-lives, and according to the 2023 CNS Drugs review neither is among the highest-risk drugs, unlike Paxil and SNRIs. How tapering goes depends more on how long you’ve been on the medication, the pace of the taper and individual sensitivity than on the drug itself.
Can liquid Lexapro make tapering easier?
A liquid form allows much smaller dose changes than tablets, which can make a gradual taper easier. It doesn’t guarantee a symptom-free process, and switching formulations and setting the pace are decisions for your prescriber.
What should you do if withdrawal symptoms are severe?
Contact your prescriber. The prescribing information says that going back to the previous dose and then tapering more slowly may be considered. If you have thoughts of suicide, call or text 988 in the US, call Samaritans on 116 123 in the UK, or call your local emergency number.
Conclusion
Coming off Lexapro is possible, but it takes a plan and patience. Most of what happens depends on pace and formulation: small, progressively smaller steps, adjusted to how you respond, give your nervous system time to adapt.
Before you start, talk to your prescriber about the formulation, the pace and a plan for harder days. An informed decision, based on solid information, makes the process steadier and easier to manage.
Considering Coming Off Lexapro? Protracted Withdrawal Can Help
Protracted Withdrawal supports people who have decided, together with their prescriber, to come off antidepressants. The program offers education on hyperbolic tapering, help making sense of symptoms and observations, and preparation for conversations with your prescriber. Decisions about doses always stay with your doctor. You can read how antidepressant tapering support works and compare the support programs and pricing.
If you’d rather go at your own pace, you can join the antidepressant tapering support group. You’ll find more videos about coming off medication on the Protracted Withdrawal YouTube channel.
Want to explore safe tapering?
Talk through your situation and find out what support could look like while you come off Lexapro.
This content is for educational purposes only and is not medical advice. Always make decisions about your medication with your prescriber. In an emergency, call 911 in the US or 999 in the UK. For crisis support, call or text 988 (Suicide & Crisis Lifeline) in the US, or call Samaritans on 116 123 in the UK and Ireland.
References
- Allergan. (2023). LEXAPRO (escitalopram) tablets: Prescribing information. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13bb8267-1cab-43e5-acae-55a4d957630a
- Bousman, C. A., Stevenson, J. M., Ramsey, L. B., Sangkuhl, K., Hicks, J. K., Strawn, J. R., et al. (2023). Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clinical Pharmacology & Therapeutics, 114(1), 51-68. https://doi.org/10.1002/cpt.2903
- Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors, 97, 111-121. https://doi.org/10.1016/j.addbeh.2018.08.027
- European Medicines Agency. (2019). PRAC recommendations on signals adopted at the 13-16 May 2019 PRAC meeting. https://www.ema.europa.eu/en/documents/prac-recommendation/prac-recommendations-signals-adopted-13-16-may-2019-prac-meeting_en.pdf
- Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020). Protracted withdrawal syndrome after stopping antidepressants: A descriptive quantitative analysis of consumer narratives from a large internet forum. Therapeutic Advances in Psychopharmacology, 10. https://doi.org/10.1177/2045125320980573
- Henssler, J., Schmidt, Y., Schmidt, U., Schwarzer, G., Bschor, T., & Baethge, C. (2024). Incidence of antidepressant discontinuation symptoms: A systematic review and meta-analysis. The Lancet Psychiatry, 11(7), 526-535. https://doi.org/10.1016/S2215-0366(24)00133-0
- Horowitz, M. A., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6(6), 538-546. https://doi.org/10.1016/S2215-0366(19)30032-X
- Horowitz, M. A., Framer, A., Hengartner, M. P., Sørensen, A., & Taylor, D. (2023). Estimating risk of antidepressant withdrawal from a review of published data. CNS Drugs, 37(2), 143-157. https://doi.org/10.1007/s40263-022-00960-y
- National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NICE guideline NG222). https://www.nice.org.uk/guidance/ng222
- Royal College of Psychiatrists. (n.d.). Stopping antidepressants. https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants
